Acurx Pharmaceuticals
ACXP
ACXP
22 hedge funds and large institutions have $2.41M invested in Acurx Pharmaceuticals in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% less call options, than puts
Call options by funds: $17K | Put options by funds: $25K
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Holders
22
Holding in Top 10
–
Calls
$17K
Puts
$25K
Top Buyers
| 1 | +$71.6K | |
| 2 | +$33.8K | |
| 3 | +$32.3K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$31.3K |
| 5 |
BlackRock
New York
|
+$1.98K |
Top Sellers
| 1 | -$23K | |
| 2 | -$17K | |
| 3 | -$9.21K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$3.96K |
| 5 |
Simplex Trading
Chicago,
Illinois
|
-$3.03K |